A case report of the sustained and rapid response of bevacizumab in a TP53-positive breast cancer and liver metastatic patient through personalized medicine

HER2-positive metastatic breast cancer is much less frequent than other subgroups of breast cancer. Treatment options for this cancer are mostly limited to systemic chemotherapy, which leads to moderate improvements. Targeted therapy against malignant breast cancer requires the identification of rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskandarion, Mohammad Reza, Tizmaghz, Zahra, Andalib, Bahram, Parsa, Nasser, Emami, Seyed Amir Hossein, Shahsiah, Reza, Oghabian, Mohammad Ali, Shirkoohi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479335/
https://www.ncbi.nlm.nih.gov/pubmed/36119510
http://dx.doi.org/10.3389/fonc.2022.940678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479335/
https://www.ncbi.nlm.nih.gov/pubmed/36119510
http://dx.doi.org/10.3389/fonc.2022.940678

Ejemplares similares